Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 12 recruiting now full pipeline

Ventricular Tachycardia: full-pipeline trial registry

12 of 29 indexed Ventricular Tachycardia trials are currently recruiting.

Corpus placement: #552 of 28,707 conditions by registered trial count.

29 US clinical trials · 12 currently recruiting · #552 of 28,707 conditions by registered trial count

Ventricular Tachycardia: 29 US clinical trials tracked, 12 recruiting.

Ventricular Tachycardia is the subject of 29 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Vanderbilt University Medical Center, running 3 of these trials.

Enrollment posture brief

Registry condition ventricular-tachycardia

OPEN 12 | RECR 41% | LATE 2 | EARLY 3 | RANK #552 | SPON 3

Nearest open-share peer: Dyslipidemias (41% recruiting · 29 trials)

Advanced Breast Cancer62.1%Amyloidosis51.7%Ventricular Tachycardia (thi…41%Arthritis, Rheumatoid17.2%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Ventricular Tachycardia

Ventricular Tachycardia lists 12 open slots (41% of 29 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ventricular Tachycardia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ventricular Tachycardia recruits in line with its size-band peers.

    12 of 29 indexed trials (41.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Ventricular Tachycardia trials is spread across many organizations.

    Vanderbilt University Medical Center accounts for 3 of 29 trials (10.3%). 24 distinct sponsors appear on at least one study for this condition label.

  3. Typical Ventricular Tachycardia enrolment sits around 115 participants.

    Median target enrolment is 115 among the 29 trials that report a genuine target (sentinel values excluded). 12 of those (41.4%) plan for fewer than 100 participants.

  4. Ventricular Tachycardia splits between interventional and observational designs.

    20 interventional and 9 observational studies make up this index (69% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22Phase 31Phase 41

Open and recent trials

29 total, page 1 of 1

RECRUITING 200 participants

Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation

Vanderbilt University Medical Center

NCT06647459

RECRUITING NA 200 participants

The Z Stitch Early Bed Rest Assessment Study

Oregon Health and Science University

NCT06087497

RECRUITING 200 participants

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

Vanderbilt University Medical Center

NCT06575881

RECRUITING Phase 2 156 participants

Venous Ethanol for Ventricular Tachycardia

The Methodist Hospital Research Institute

NCT05511246

RECRUITING 130 participants

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

CorVita Science Foundation

NCT06455488

RECRUITING NA 100 participants

Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy

Rush University Medical Center

NCT06138873

RECRUITING NA 60 participants

Randomized Assessment of TcMS for VT Storm

University of Pennsylvania

NCT05599022

RECRUITING NA 40 participants

Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia

Pasquale Santangeli

NCT06891456

RECRUITING NA 40 participants

Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions

Weill Medical College of Cornell University

NCT06743789

RECRUITING NA 24 participants

Cardiac Radioablation for VT

Corewell Health East

NCT06593418

RECRUITING Early Phase 1 20 participants

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

University of Pennsylvania

NCT05377216

RECRUITING NA 10 participants

Ventricular Tachycardia Mechanisms

Emory University

NCT05478213

ACTIVE NOT RECRUITING 2,200 participants

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Medtronic

NCT04496518

ACTIVE NOT RECRUITING NA 300 participants

Assessment of Combined CCM and ICD Device in HFrEF

Impulse Dynamics

NCT05855135

ACTIVE NOT RECRUITING 62 participants

Abbott Ventricular Tachycardia PAS

Abbott Medical Devices

NCT05839873

COMPLETED 1,326 participants

INSIGHTS ICD Registry

Medtronic Cardiac Rhythm and Heart Failure

NCT00279968

COMPLETED NA 1,173 participants

Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

Boston Scientific Corporation

NCT02433379

COMPLETED NA 592 participants

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

Abbott Medical Devices

NCT03490201

COMPLETED 400 participants

Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial

CardioDx

NCT00583297

COMPLETED NA 181 participants

Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies

Catheter Robotics

NCT01139814

COMPLETED 142 participants

First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data

Boston Scientific Corporation

NCT01161589

COMPLETED Phase 3 120 participants

Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation

Texas Cardiac Arrhythmia Research Foundation

NCT01045668

COMPLETED NA 115 participants

Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia

William Stevenson

NCT01791543

COMPLETED Phase 4 100 participants

The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock

Mayo Clinic

NCT00787800

COMPLETED Phase 2 68 participants

A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.

Vanderbilt University Medical Center

NCT04134845

COMPLETED NA 48 participants

REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients

Vivek Reddy

NCT01747837

COMPLETED NA 45 participants

VIVO™ Accuracy Study

Catheter Precision.

NCT03340142

COMPLETED NA 20 participants

Imaging With a Radio Tracer to Guide VT Ablations

University of Maryland, Baltimore

NCT01250912

COMPLETED 11 participants

Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia

Dhanunjaya Lakkireddy, MD, FACC

NCT01695551

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Ventricular Tachycardia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

FlexAbility SE Ablation Catheter Device
2 trials
Market Approved RF Ablation System Device
1 trials
VIVO™ Device
1 trials
123I-metaiodobenzylguanidine Drug
1 trials
Single Chamber ICD Device
1 trials
Dual Chamber ICD Device
1 trials
Dantrolene/Ryanodex Drug
1 trials
Amigo catheter robot Device
1 trials

US sites by state

Facility locations filed on Ventricular Tachycardia trials. A trial with sites in several states counts in each.

Illinois 7 trials
Florida 7 trials
Texas 6 trials
Tennessee 6 trials
Maryland 6 trials
California 6 trials
South Carolina 5 trials
Pennsylvania 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ventricular Tachycardia page

29 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ventricular Tachycardia condition card totals 29 registered trials; most-linked intervention FlexAbility SE Ablation Catheter; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.